期刊
BIOCHEMISTRY
卷 46, 期 1, 页码 245-252出版社
AMER CHEMICAL SOC
DOI: 10.1021/bi061646s
关键词
-
资金
- Medical Research Council [MC_U123170362, MC_U123160656, MC_U123192748, MC_U123160655] Funding Source: Medline
- MRC [MC_U123170362, MC_U123160656, MC_U123160655] Funding Source: UKRI
- Medical Research Council [MC_U123160655, MC_U123170362, MC_U123160656] Funding Source: researchfish
Disease-related prion protein, PrP(Sc), can be distinguished from its normal cellular precursor, PrP(C), by its detergent insolubility and partial resistance to proteolysis. Several studies have suggested that copper(II) ions can convert PrP(C) to a proteinase K-resistant conformation; however, interpretation of these studies is complicated by potential inhibition of proteinase K (PK) by copper(II) ions. Here we have examined directly the kinetic and equilibrium effects of copper(II) ions on PK activity using a simple synthetic substrate, p-nitrophenyl acetate. We show that at equilibrium two to three copper(II) ions bind stoichiometrically to PK and destroy its activity (K(d) < 1 mu M). This inhibition has two components, an initial reversible and weak binding phase and a slower, irreversible abolition of activity with a half-time of 6 min at saturating copper(II) ion concentrations. Copper(II) ions produce a similar biphasic inhibition of PK activity in the presence of brain homogenate but only when the copper(II) ion concentration exceeds that of the chelating components present in brain tissue. Under these conditions, the apparent resistance of PrP(C) to proteolysis by PK appears to be directly attributable to the inhibition of PK activity by copper(II) ions.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据